Esophageal Varices Clinical Trial
Official title:
Timing of Upper Endoscopy in Cirrhotic Patients With Upper Gastrointestinal Bleeding: Urgent vs. Elective Endoscopy
Liver cirrhosis is a common diffuse and persistent liver disease often accompanied by portal hypertension, liver failure, upper gastrointestinal bleeding (UGIB), and other complications. The incidence rate of liver cirrhosis with UGIB is as high as 30-40%, which is related to the rupture bleeding of gastroesophageal varices (GOV), hepatogenic ulcer, portal hypertensive gastropathy, hepatic gastrointestinal failure, etc
In the case of UGIB in patients with liver cirrhosis, acute peripheral circulatory failure may suddenly occur, resulting in decreased blood perfusion in liver tissues, often accompanied by clinical manifestations such as blood volume decline, melena, and haematemesis. This disease progresses rapidly, with a mortality rate of above 10% if not treated promptly Timing of endoscopy in the management of acute upper gastrointestinal bleeding (AUGIB) has been a subject of perennial debate. Despite remarkable advancements in endoscopic treatments and substantial efforts in reducing mortality, the overall in-hospital mortality rate associated with UGIB is still estimated to be 10%. Several studies have investigated the clinical impact of urgent (within 6 h of presentation) or early (within 12 h) endoscopy on mortality in patients with UGIB. Some studies showed no significant difference in mortality rate between urgent and elective endoscopy groups among high-risk patients with acute UGIB In contrast, others found that urgent endoscopy was associated with a lower mortality rate in high-risk patients with acute non-variceal UGIB. Most of the previous studies included highly selected patients with non-variceal UGIB or those at a high risk. However, given that the definitive diagnosis is made after endoscopic examination, these studies may not reflect real-world clinical practice. Furthermore, it is often challenging to predict the cause of bleeding and to identify patients at high risk who require intensive care based on their symptoms and the information obtained in the emergency room ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06017102 -
Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices
|
N/A | |
Recruiting |
NCT03624517 -
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
|
Phase 4 | |
Recruiting |
NCT03989973 -
Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis
|
||
Completed |
NCT05485714 -
Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
|
||
Completed |
NCT01851252 -
MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy
|
Phase 1 | |
Completed |
NCT01360515 -
A Study of Disposable Transnasal Esophagoscope
|
N/A | |
Recruiting |
NCT04602663 -
Optimal Time for Follow up After Variceal Band Ligation
|
N/A | |
Recruiting |
NCT04499898 -
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
|
Phase 2/Phase 3 | |
Completed |
NCT00331188 -
Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
|
Phase 3 | |
Enrolling by invitation |
NCT02767206 -
Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.
|
N/A | |
Enrolling by invitation |
NCT05781828 -
Noninvasive Methods For Prediction of Esophageal Varices in Children
|
||
Not yet recruiting |
NCT05199038 -
Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study
|
Phase 4 | |
Recruiting |
NCT02740166 -
Preventing Recurrent Bleeding After Eradication of Esophageal Varices
|
Phase 4 | |
Completed |
NCT01893541 -
PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?
|
Phase 4 | |
Terminated |
NCT00485290 -
Effect of Meal on Portal and Esophagus Variceal Pressure
|
N/A | |
Completed |
NCT01079416 -
Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices
|
N/A | |
Completed |
NCT01188733 -
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04254822 -
HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients
|
N/A | |
Recruiting |
NCT03212872 -
Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding
|
N/A | |
Completed |
NCT03748563 -
Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis
|
N/A |